NEOADJUVANT CHEMOTHERAPY IN MARGINALLY RESECTABLE STAGE-III MO NON-SMALL CELL LUNG-CANCER - LONG-TERM FOLLOW-UP IN 41 PATIENTS

被引:140
|
作者
SKARIN, A
JOCHELSON, M
SHELDON, T
MALCOLM, A
OLIYNYK, P
OVERHOLT, R
HUNT, M
FREI, E
机构
[1] NEW ENGLAND BAPTIST HOSP, DEPT SURG, BOSTON, MA USA
[2] NEW ENGLAND DEACONESS HOSP, DEPT SURG, BOSTON, MA 02215 USA
关键词
D O I
10.1002/jso.2930400413
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:266 / 274
页数:9
相关论文
共 50 条
  • [21] COMBINATION CARBOPLATIN AND RADIATION IN THE TREATMENT OF STAGE-III (MO) NON-SMALL-CELL LUNG-CANCER
    SLAWSON, RG
    BELANI, C
    HIPONIA, D
    ENGSTROM, C
    AISNER, J
    SALAZAR, OM
    [J]. RADIOLOGY, 1992, 185 : 218 - 218
  • [22] Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer
    Bunn, Paul A., Jr.
    Gaspar, Laurie E.
    Weyant, Michael J.
    Mitchell, John D.
    [J]. CANCER, 2016, 122 (05) : 674 - 675
  • [23] Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
    Roth, JA
    Atkinson, EN
    Fossella, F
    Komaki, R
    Ryan, MB
    Putnam, JB
    Lee, JS
    Dhingra, H
    De Caro, L
    Chasen, M
    Hong, WK
    [J]. LUNG CANCER, 1998, 21 (01) : 1 - 6
  • [24] EFFICACY OF CHEMOTHERAPY WITH CISPLATIN, VINDESINE AND MITOMYCIN IN NON-SMALL-CELL LUNG-CANCER, STAGE-III
    RIGGI, M
    RUFFIE, P
    LECHEVALIER, T
    MUNCK, JN
    CVITKOVIC, E
    OLIVEIRA, J
    ARMAND, JP
    [J]. BULLETIN DU CANCER, 1988, 75 (07) : 628 - 629
  • [25] NEOADJUVANT CHEMOTHERAPY AND RADIOTHERAPY IN NON-SMALL CELL LUNG-CANCER (NSCLC)
    WATKIN, SW
    ERRINGTON, RD
    GREEN, JA
    WARENIUS, HM
    [J]. BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 231 - 231
  • [26] Phase II Trial of Neoadjuvant Tislelizumab with Chemotherapy for Resectable Stage IIB-III Non-small Cell Lung Cancer
    Lin, Y-B
    Long, H.
    Chen, Y-H
    Zhai, W-Y
    Wang, Y-Z
    Rao, B-Y
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S287 - S287
  • [27] Neoadjuvant Combination Sintilimab plus Chemotherapy in Patients with Resectable Stage IIIA Non-Small Cell Lung Cancer.
    Ma, K.
    Sun, C.
    Jia, X.
    Wang, X.
    Xu, Y.
    Guo, Y.
    Qiu, S.
    Shao, G.
    Zhang, P.
    Liu, Y.
    Ma, X.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S649 - S650
  • [28] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Laura Gutierrez-Sainz
    Patricia Cruz-Castellanos
    Oliver Higuera
    Javier de Castro-Carpeño
    [J]. Current Treatment Options in Oncology, 2021, 22
  • [29] Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
    Broderick, Stephen R.
    Bott, Matthew J.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (05): : 1471 - 1474
  • [30] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Gutierrez-Sainz, Laura
    Cruz-Castellanos, Patricia
    Higuera, Oliver
    De Castro-Carpeno, Javier
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)